Baseline, n (%) | 4-year follow-up post-intervention, n (%) | p-value Baseline to 4-year follow-up post-interventiona | p-value Intervention vs. Controlb | ||
---|---|---|---|---|---|
WHO Criteriac | |||||
OW | |||||
Intervention | Boys | 39 (21.9) | 31 (17.4) | 0.322 | 0.314 |
Girls | 38 (22.2) | 12 (7.0) | <0.001 | 0.602 | |
Total | 77 (22.1) | 43 (12.3) | <0.001 | 0.238 | |
Control | Boys | 8 (11.8) | 6 (8.8) | 0.774 | |
Girls | 18 (20.9) | 12 (14.0) | 0.286 | ||
Total | 26 (16.9) | 18 (11.7) | 0.229 | ||
OB | |||||
Intervention | Boys | 24 (13.5) | 3 (1.7) | <0.001 | 0.019 |
Girls | 11 (6.4) | 4 (2.3) | 0.039 | 0.560 | |
Total | 35 (10.0) | 7 (2.0) | <0.001 | 0.205 | |
Control | Boys | 5 (7.4) | 3 (4.4) | 0.500 | |
Girls | 6 (7.0) | 2 (2.3) | 0.289 | ||
Total | 11 (7.1) | 5 (3.2) | 0.109 | ||
IOTF Criteriad | |||||
OW | |||||
Intervention | Boys | 39 (21.9) | 30 (16.9) | 0.163 | 0.238 |
Girls | 30 (17.5) | 11 (6.4) | 0.002 | 0.581 | |
Total | 69 (19.8) | 41 (11.7) | 0.001 | 0.244 | |
Control | Boys | 6 (8.8) | 3 (4.4) | 0.375 | |
Girls | 18 (20.9) | 9 (10.5) | 0.022 | ||
Total | 24 (15.6) | 5 (3.2) | 0.008 | ||
OB | |||||
Intervention | Boys | 4 (2.2) | 1 (0.6) | 0.375 | 0.578 |
Girls | 8 (4.7) | 4 (2.3) | 0.289 | 0.430 | |
Total | 12 (3.4) | 5 (1.4) | 0.092 | 0.186 | |
Control | Boys | 3 (4.4) | 3 (4.4) | 1.000 | |
Girls | 1 (1.2) | 2 (2.3) | 1.000 | ||
Total | 4 (2.6) | 5 (3.2) | 1.000 |